In samples with available information about patient outcomes, we observed that low UBE4B protein expression was associated with a non-significant trend towards decreased survival (Supplemental Figure 6), further suggesting that the association of UBE4B gene expression with neuroblastoma patient outcomes is mediated by UBE4B protein expression and function. Here, UBE4B is linked to neuroblastoma.